As mpox outbreak spreads across Africa, Siga's antiviral Tpoxx misses the bar in Congo study
Fierce Pharma
AUGUST 15, 2024
Just as a new strain of mpox spreads across Africa, results from a preliminary analysis of a study that began during the 2022 viral outbreak stands to provide more clarity on the clinical benefit o | Despite missing the trial's primary endpoint of time to lesion resolution, the study suggested that the treatment may be most beneficial for those treated early and those with severe disease.
Let's personalize your content